EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Which clinical research questions are the most important? Development and preliminary validation of the Australia & New Zealand Musculoskeletal (ANZMUSC) Clinical Trials Network Research Question Importance Tool (ANZMUSC-RQIT)

William J Taylor iD, Robin Willink iD, Denise A O'Connor iD, Vinay Patel, Allison Bourne, Ian A Harris iD, Samuel L Whittle, Bethan Richards, Ornella Clavisi, Sally Green, Rana S Hinman, Chris G Maher iD und 13 weitere

PLOS ONE · 17.03.2023 · 18 (3) · e0281308

DOI: 10.1371/journal.pone.0281308 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 17.03.2023. Verfasst von William J Taylor und 24 weiteren Autor:innen. Beteiligte Einrichtung: University of Otago, Wellington, New Zealand. Hauptthemen laut MEDLINE: Publications. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and aims High quality clinical research that addresses important questions requires significant resources. In resource-constrained environments, projects will therefore need to be prioritized. The Australia and New Zealand Musculoskeletal (ANZMUSC) Clinical Trials Network aimed to develop a stakeholder-based, transparent, easily implementable tool that provides a score for the ‘importance’ of a research question which could be used to rank research projects in order of importance.

Methods

Using a mixed-methods, multi-stage approach that included a Delphi survey, consensus workshop, inter-rater reliability testing, validity testing and calibration using a discrete-choice methodology, the Research Question Importance Tool (ANZMUSC-RQIT) was developed. The tool incorporated broad stakeholder opinion, including consumers, at each stage and is designed for scoring by committee consensus.

Results

The ANZMUSC-RQIT tool consists of 5 dimensions (compared to 6 dimensions for an earlier version of RQIT): (1) extent of stakeholder consensus, (2) social burden of health condition, (3) patient burden of health condition, (4) anticipated effectiveness of proposed intervention, and (5) extent to which health equity is addressed by the research. Each dimension is assessed by defining ordered levels of a relevant attribute and by assigning a score to each level. The scores for the dimensions are then summed to obtain an overall ANZMUSC-RQIT score, which represents the importance of the research question. The result is a score on an interval scale with an arbitrary unit, ranging from 0 (minimal importance) to 1000. The ANZMUSC-RQIT dimensions can be reliably ordered by committee consensus (ICC 0.73–0.93) and the overall score is positively associated with citation count (standardised regression coefficient 0.33, p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PublicationsHumansNew ZealandReproducibility of ResultsConsensusAustralia

Autor:innen und Institutionen

  • University of Otago, Wellington, New Zealand.
  • Hutt Valley District Health Board, Lower Hutt, New Zealand.
  • Hauora Tairawhiti, Gisborne, New Zealand.
  • Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Victoria, Australia.
  • Monash-Cabrini Department of Musculoskeletal Health and Clinical Epidemiology, Cabrini Health, Victoria, Australia.
  • Whitlam Orthopaedic Research Centre, Ingham Institute for Applied Medical Research, Liverpool, Australia.

ORCID-Profile: William J Taylor, Robin Willink, Denise A O'Connor, Ian A Harris, Chris G Maher, Laurent Billot

Förderung

  • National Health and Medical Research Council

Zitieren

APA

Taylor, W. J., Willink, R., O'Connor, D. A., Patel, V., Bourne, A., Harris, I. A., Whittle, S. L., Richards, B., Clavisi, O., Green, S., Hinman, R. S., Maher, C. G., Cahill, A., McPherson, A., Hewson, C., May, S. E., Walker, B., Robinson, P. C., Ghersi, D., …, & Buchbinder, R. (2023). Which clinical research questions are the most important? Development and preliminary validation of the Australia & New Zealand Musculoskeletal (ANZMUSC) Clinical Trials Network Research Question Importance Tool (ANZMUSC-RQIT). PLOS ONE, 18(3), e0281308. https://doi.org/10.1371/journal.pone.0281308

Vancouver

Taylor WJ, Willink R, O'Connor DA, Patel V, Bourne A, Harris IA, et al. Which clinical research questions are the most important? Development and preliminary validation of the Australia & New Zealand Musculoskeletal (ANZMUSC) Clinical Trials Network Research Question Importance Tool (ANZMUSC-RQIT). PLOS ONE. 2023;18(3):e0281308. doi:10.1371/journal.pone.0281308

BibTeX
@article{Taylor2023,
  author = {Taylor, William J and Willink, Robin and O'Connor, Denise A and Patel, Vinay and Bourne, Allison and Harris, Ian A and Whittle, Samuel L and Richards, Bethan and Clavisi, Ornella and Green, Sally and Hinman, Rana S and Maher, Chris G and Cahill, Ainslie and McPherson, Annie and Hewson, Charlotte and May, Suzie E and Walker, Bruce and Robinson, Philip C and Ghersi, Davina and Fitzpatrick, Jane and Winzenberg, Tania and Fallon, Kieran and Glasziou, Paul and Billot, Laurent and Buchbinder, Rachelle},
  title = {Which clinical research questions are the most important? Development and preliminary validation of the Australia & New Zealand Musculoskeletal (ANZMUSC) Clinical Trials Network Research Question Importance Tool (ANZMUSC-RQIT)},
  journal = {PLOS ONE},
  year = {2023},
  volume = {18},
  number = {3},
  pages = {e0281308},
  doi = {10.1371/journal.pone.0281308}
}
Kostenlos starten →